TrialSignal transduction and targeted therapy2026

Efficacy and safety of toripalimab in combination with cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): a phase 1b/2 study.

Ye Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.